Blood and Marrow Transplant Clinical Research Network

This study has been completed.
Sponsor:
Collaborator:
Blood and Marrow Transplant Clinical Trials Network
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00023530
First received: September 7, 2001
Last updated: November 29, 2007
Last verified: July 2006
  Purpose

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.


Condition Intervention
Bone Marrow Transplantation
Blood Disease
Hematopoietic Stem Cell Transplantation
Leukemia
Multiple Myeloma
Myelodysplastic Syndromes
Graft vs Host Disease
Drug: fluconazole
Drug: voriconazole
Procedure: bone marrow transplant
Drug: thalidomide
Drug: dexamethasone

Study Type: Interventional
Study Design: Allocation: Randomized
Masking: Double-Blind
Primary Purpose: Prevention
Official Title: Blood and Marrow Transplant Clinical Research Network

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 2001
Study Completion Date: August 2006
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   2 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Criteria for entry into a study varies by protocol

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00023530

Locations
United States, California
City of Hope National Medical Center
Duarte, California, United States, 91010
University of California at San Diego
La Jolla, California, United States, 92093
Stanford University
Palo Alto, California, United States, 94305
United States, Florida
University of Florida
Gainesville, Florida, United States, 32610
United States, Maryland
Johns Hopkins University
Baltimore, Maryland, United States, 21231
United States, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
United States, Michigan
University of Michigan at Ann Arbor
Ann Arbor, Michigan, United States, 48109
United States, Minnesota
University of Minnesota Twin Cities
Minneapolis, Minnesota, United States, 55455
United States, Missouri
Children's Mercy Hospital
Kansas City, Missouri, United States, 64108
United States, Nebraska
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198
United States, New York
Sloan-Kettering Institute for Cancer Research
New York, New York, United States, 10021
United States, North Carolina
Duke University
Durham, North Carolina, United States, 27705
United States, Ohio
Case Western Reserve University
Cleveland, Ohio, United States, 44106
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
United States, Texas
MD Anderson Cancer Center
Houston, Texas, United States, 77030
United States, Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States, 98109
Sponsors and Collaborators
Blood and Marrow Transplant Clinical Trials Network
Investigators
Investigator: Joseph Antin Dana-Farber Cancer Institute
Investigator: Frederick Appelbaum Fred Hutchinson Cancer Research Center
Investigator: Edward Ball University of California, San Diego
Investigator: James Ferrara University of Michigan at Ann Arbor
Investigator: Stephen Forman City of Hope National Medical Center
Investigator: Alan Gamis Children's Mercy Hospital
Investigator: Sergio Giralt M.D. Anderson Cancer Center
Investigator: Mary Horowitz Medical College of Wisconsin
Investigator: Richard Jones Johns Hopkins University
Investigator: Joanne Kurtzberg Duke University
Investigator: Gina Laport Stanford University
Investigator: Hillard Lazarus Case Western Reserve University
Investigator: Richard O'Reilly Sloan-Kettering Institute for Cancer Research
Investigator: Edward Stadtmauer University of Pennsylvania
Investigator: Julie Vose University of Nebraska
Investigator: Daniel Weisdorf University of Minnesota - Clinical and Translational Science Institute
Investigator: John Wingard University of Florida
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00023530     History of Changes
Other Study ID Numbers: 139
Study First Received: September 7, 2001
Last Updated: November 29, 2007
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Graft vs Host Disease
Hematologic Diseases
Leukemia
Multiple Myeloma
Neoplasms, Plasma Cell
Myelodysplastic Syndromes
Preleukemia
Immune System Diseases
Neoplasms by Histologic Type
Neoplasms
Hemostatic Disorders
Vascular Diseases
Cardiovascular Diseases
Paraproteinemias
Blood Protein Disorders
Hemorrhagic Disorders
Lymphoproliferative Disorders
Immunoproliferative Disorders
Bone Marrow Diseases
Precancerous Conditions
Dexamethasone acetate
Dexamethasone
Dexamethasone 21-phosphate
Thalidomide
BB 1101
Fluconazole
Voriconazole
Anti-Inflammatory Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on July 31, 2014